Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal ...

In a deal nearly two years in the making, Bioventus has opted to acquire fellow orthopedic devicemaker CartiHeal—less than a week after CartiHeal announced its flagship cartilage repair implant ...

DURHAM – In the latest twist of an acquisition saga dating back some three years Durham-based life science firm Bioventus is to pay millions of dollars to shareholders of a company it announced plans ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Bioventus announced its first-quarter 2024 financial ...

Fintel reports that on February 9, 2026, Barrington Research initiated coverage of Bioventus (NasdaqGS:BVS) with a Outperform ...

Barely a month after the plan was unveiled, Bioventus’ acquisition of fellow orthopedic devicemaker CartiHeal appears to be on much shakier ground. Bioventus has walked away from an offering of senior ...

After going public with a $100 million initial public offering earlier this year, Bioventus has now made its largest-ever acquisition. The Durham biotechnology company, which makes treatments for knee ...

Michelle McMurryHeath, Director at Bioventus (NASDAQ:BVS), reported an insider sell on November 10, according to a new SEC filing. What Happened: McMurryHeath's recent move involves selling 17,701 ...

DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in ...

The medical technology company Bioventus jumped deeper into biotech’s tumultuous waters on Thursday by registering a $150 million initial public stock offering. Headquartered in Durham, North Carolina ...

DURHAM – Bioventus is getting ready to make another big acquisition. The global orthobiologics company headquartered in Durham has agreed to make a $50 million escrow payment to Israeli med tech ...